Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LATOYA COFIELD

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1376194332
CMS profile
10903929
Location
LAWRENCEVILLE, GA

General Payments · PY2021–2024

$797.14

  • Reported across 30 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$441.48

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $441.48 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $13.58 1
PY2022 $78.77 4
PY2023 $263.31 9
PY2024 $441.48 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.38 01/17/2024 Food and Beverage Undisputed 01/23/2026 1117226492 CMS
Amgen Inc. $26.29 11/04/2024 Food and Beverage Undisputed 01/23/2026 1117226494 CMS
AstraZeneca Pharmaceuticals LP $21.85 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104223847 CMS
Aurinia Pharma U.S., Inc. $14.37 01/09/2024 Food and Beverage Undisputed 01/23/2026 1150696120 CMS
Aurinia Pharma U.S., Inc. $20.49 03/20/2024 Food and Beverage Undisputed 01/23/2026 1150696122 CMS
Aurinia Pharma U.S., Inc. $20.69 05/08/2024 Food and Beverage Undisputed 01/23/2026 1150696124 CMS
Aurinia Pharma U.S., Inc. $22.52 08/14/2024 Food and Beverage Undisputed 01/23/2026 1150696126 CMS
Aurinia Pharma U.S., Inc. $22.52 11/05/2024 Food and Beverage Undisputed 01/23/2026 1150696128 CMS
Bayer Healthcare Pharmaceuticals Inc. $138.08 03/09/2024 Food and Beverage Undisputed 01/23/2026 1086271998 CMS
Bayer Healthcare Pharmaceuticals Inc. $27.68 10/01/2024 Food and Beverage Undisputed 01/23/2026 1086325164 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.03 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086289650 CMS
CALLIDITAS THERAPEUTICS US INC. $13.28 06/05/2024 Food and Beverage Undisputed 01/23/2026 1141516401 CMS
CALLIDITAS THERAPEUTICS US INC. $21.00 12/18/2024 Food and Beverage Undisputed 01/23/2026 1141529821 CMS
Fresenius USA Marketing, Inc. $24.51 03/06/2024 Food and Beverage Undisputed 01/23/2026 1154206584 CMS
GlaxoSmithKline, LLC. $14.59 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116520322 CMS
Lilly USA, LLC $15.20 01/08/2024 Food and Beverage Undisputed 01/23/2026 1135738848 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.